Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC35629 structure
    GC35629CDDO-dhTFEA
    CAS: 1191265-33-4
    纯度: >99.50%

    CDDO-dhTFEA (RTA dh404) 是一种合成的齐墩果烷三萜化合物,有效激活 Nrf2 并抑制促炎转录因子 NF-κB。 CDDO-dhTFEA 可以恢复高血压 (MAP),增加 Nrf2 及其靶基因的表达,减弱 NF-κB 的活化和转化生长因子-β 途径,并减少慢性肾病 (CKD) 大鼠的肾小球硬化,间质纤维化和炎症。

  • GC35630 structure
    GC35630CDDO-EA
    CAS: 932730-51-3
    纯度: >98.00%

    CDDO-EA 是一种 NF-E2 相关因子 2 /抗氧化反应元件 (Nrf2/ARE) 激活剂。

  • GC35674 structure
    GC35674Chicanine
    CAS: 78919-28-5

    Chicanine 是五味子中的木酚素类化合物,可抑制 LPS 诱导的 p38 MAPK,ERK 1/2 和 IκB-α 的磷酸化水平,具有抗炎活性。

  • GC35703 structure
    GC35703Citicoline
    CAS: 987-78-0
    纯度: >99.50%

    An intermediate in the synthesis of phosphatidylcholine

  • GC35724 structure
    GC35724Complement C5-IN-1
    CAS: 2365402-67-9
    纯度: >98.00%

    Compound C5-IN-1 (Compound 7) 是补体成分蛋白5 (C5) 的小分子抑制剂。Compound C5-IN-1 与 C5 相互作用以防止其被 C5 转化酶切割, 阻断酵母多糖诱导的 50%人全血 MAC 沉积的 IC50 值为 0.77 μM。

  • GC35853 structure
    GC35853diABZI STING agonist-1
    CAS: 2138299-33-7
    纯度: >99.00% / >98.00%

    diABZI STING agonist-1是干扰素基因刺激物(STING)途径的激动剂,其在人和小鼠中的EC50值分别为130nM 和186nM。

  • GC35854 structure
    GC35854diABZI STING agonist-1 Tautomerism
    CAS: 2138498-18-5
    纯度: >98.00%

    diABZI STING agonist (diABZI STING agonist-1, Compound 3, Tautomerism) is a potent non-nucleotide STING agonist and has tremendous potential to improve treatment of cancer in humans.

  • GC35855 structure
    GC35855diABZI STING agonist-1 trihydrochloride
    CAS: 2138299-34-8
    纯度: >98.50% / >98.00%

    diABZI STING agonist-1 trihydrochloride 作为一种 STING 激动剂,通过未知受体内化到细胞质中并诱导 STING 的激活和二聚化,然后是 TBK1/IRF3 磷酸化,从而导致 I 型 IFN 反应。

  • GC35996 structure
    GC35996Epiberberine chloride
    CAS: 889665-86-5
    纯度: >99.50%

    An alkaloid with diverse biological activities

  • GC36006 structure
    GC36006Esculentoside H
    CAS: 66656-92-6
    纯度: >98.00%

    Esculentoside H (EsH) 是从多年生植物 Phytolacca esculent 的根提取物中分离和纯化的水溶性皂苷。Esculentoside H (EH) 具有抗肿瘤活性,其机制与 TNF 释放能力有关。Esculentoside H (EsH) 通过阻断 JNK1/2 和 NF-κB 信号介导的基质金属蛋白酶-9 (MMP-9) 表达抑制结肠癌细胞迁移。

  • GC36035 structure
    GC36035FD-IN-1
    CAS: 1646682-14-5
    纯度: >99.50%

    FD-IN-1 (Compound 12) 是一种补体因子 D (FD) 抑制剂,IC50 为 12 nM。补体因子 D 是一种高特异性的 S1 丝氨酸蛋白酶,在先天免疫系统的替代补体途径中起着重要作用。FD-IN-1 还抑制因子 XIa (FXIa) 和类胰蛋白酶 β2,IC50 分别为 7.7 和 6.5 μM。

  • GC36043 structure
    GC36043FICZ
    CAS: 172922-91-7
    纯度: >98.00%

    FICZ(甲酰吲哚 咔唑)作为芳基烃受体 (AhR) 的内源性配体,可以发挥多效性作用,包括防止炎症、纤维化和氧化应激。

  • GC36106 structure
    GC36106Gamma-glutamylcysteine (TFA)
    CAS: 283159-88-6

    Gamma-glutamylcysteine (TFA) ((γ-glutamylcysteine (TFA))是谷胱甘肽 (GSH) 合成的中间体,一种作为抗氧化酶谷胱甘肽过氧化物酶 (GPx) 的必需辅助因子的二肽。 Gamma-glutamylcysteine (TFA) 上调抗炎细胞因子 IL-10 的水平,降低促炎细胞因子 (TNF-α,IL-6 和 IL-1β) 的水平,并减弱在寡聚 Aβ40 处理的星形胶质细胞中金属蛋白酶活性的变化。

  • GC36176 structure
    GC36176Gomisin D
    CAS: 60546-10-3

    A lignan with diverse biological activities

  • GC36254 structure
    GC36254HPGDS inhibitor 2
    CAS: 2101626-26-8
    纯度: >99.50%

    HPGDS inhibitor 2 是一种高效选择性的造血前列腺素 D 合成酶 (H-PGDS) 抑制剂,IC50 值为 9.9 nM。

  • GC36262 structure
    GC36262Huangjiangsu A
    CAS: 1026020-27-8

    Huangjiangsu A 是从 D. villosa 中分离的原三角藻皂苷元。Huangjiangsu A 抗 H2O2-诱导的细胞毒性和 ROS 生成,具有肝保护作用。

  • GC36296 structure
    GC36296IFN-α Receptor Recognition Peptide 1
    CAS: 153840-64-3

    IFN-α Receptor Recognition Peptide 1 是 IFN-α 的一个多肽序列,为 IFN-α 受体识别肽。

  • GC36301 structure
    GC36301IKKγ NBD Inhibitory Peptide
    CAS: 372146-18-4

    IKKγ NBD Inhibitory Peptide是 NEMO 结合域的多肽,对应着 NEMO 氨基端α螺旋区,可以阻断 TNFα 诱导的 NF-kB 激活。

  • GC36390 structure
    GC36390Keap1-Nrf2-IN-1
    CAS: 2232112-72-8
    纯度: >98.00%

    Keap1–Nrf2 IN-1 (compound35) 是一种 Keap1- nrf2 蛋白-蛋白相互作用抑制剂,对 Keap1 蛋白作用的 IC50 值为 43 nM。Keap1–Nrf2 IN-1 (compound35) 能激活 Nrf2 调节的细胞保护反应,并在细胞和体内模型中对乙酰氨基酚诱导的肝损伤产生拮抗作用。

  • GC36443 structure
    GC36443Levomefolic acid
    CAS: 31690-09-2
    纯度: >98.50%

    Levomefolic acid是一种具有口服活性且可通过血脑屏障的叶酸生物活性形式。

  • GC36446 structure
    GC36446Licochalcone D
    CAS: 144506-15-0
    纯度: >99.50%

    Licochalcone D (Lico D, LCD, LD), a flavonoid isolated from a Chinese medicinal plant Glycyrrhiza inflata, has antioxidant, anti-inflammatory and anti-cancer properties. Licochalcone D inhibit phosphorylation of NF-κB p65 in LPS signaling pathway. Licochalcone D inhibits JAK2, EGFR and Met (c-Met) activities and induces ROS-dependent apoptosis. Licochalcone D also induces caspases activation and poly (ADP-ribose) polymerase (PARP) cleavage.

  • GC36456 structure
    GC36456Licoricidin
    CAS: 30508-27-1

    Licoricidin (LCD) 从甘草 Glycyrrhiza uralensis Fisch 中分离,具有抗癌活性。Licoricidin (LCD) 通过诱导周期停滞,诱导细胞凋亡 (apoptosis) 和自噬 (autophagy),是一种对抗结直肠癌的潜在化学预防或化学治疗剂。Licoricidin (LCD) 通过抑制肿瘤血管生成和淋巴管生成以及肿瘤组织局部微环境的变化抑制肺转移。Licoricidin (LCD) 通过体外和体内 Akt 和 NF-κB 途径的失活,增强吉西他滨诱导的骨肉瘤 (OS) 细胞的细胞毒性。Licoricidin (LCD) 通过 ROS 清除阻断 UVA 诱导的光老化,限制 MMP-1 的活性,被认为是新的局部应用的抗衰老制剂中的活性成分。

  • GC36463 structure
    GC36463Limaprost
    CAS: 74397-12-9
    纯度: >99.50%

    A stable, potent analog of PGE 1

  • GC36471 structure
    GC36471L-NIL
    CAS: 53774-63-3
    纯度: >99.50%

    A selective iNOS inhibitor